Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cycles

BACKGROUND: To determine if extended chemotherapy improves survival outcomes in patients with platinum-sensitive relapsed epithelial ovarian cancer (EOC) who have residual disease after six cycles of second-line chemotherapy. METHODS: In this study, 135 EOC patients who experienced platinum-sensitiv...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Kim, Se Ik, Hwang, Woo Yeon, Lee, Maria, Kim, Hee Seung, Kim, Kidong, Chung, Hyun Hoon, No, Jae Hong, Kim, Jae-Weon, Kim, Yong Beom, Park, Noh Hyun, Song, Yong-Sang, Suh, Dong Hoon
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7720565/
https://ncbi.nlm.nih.gov/pubmed/33287758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07658-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars